Our Vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases.
In 2019, we sold 701 million doses of vaccine around the world, 70% of which went to emerging markets. These are made in one of our 12 manufacturing sites located around the world. For some of our vaccines, this production process can take up to two years.
In Australia our vaccines portfolio helps prevent illnesses such as hepatitis, rotavirus and HPV infections, diphtheria, tetanus, whooping cough, measles, mumps, rubella, bacterial meningitis and influenza.
We are the primary supplier of childhood vaccines to the National Immunisation Program (NIP) in Australia, providing protection against potentially life threatening diseases like polio, measles, mumps and rubella to nearly 4 million children each year.